5th Annual Forced Degradation Strategies for Small Molecules
Main Conference Day Two
Wednesday, February 27th, 2008
| 8:00 | Morning Coffee |
| 8:30 |
Chair's Remarks and Recap of Day One Eric Nelson, PhD, Group Leader, JOHNSON & JOHNSON Alex Opio, PhD, Scientist, PFIZER, INC. |
| 8:45 |
Leverage Forced Degradation Testing To Improve Stability Prediction and Reduce Time to Market Stephen R. Byrn, PhD, Professor and Head, Department of Industrial and Physical Pharmacy, PURDUE UNIVERSITY |
| 9:15 |
Accelerated Stability Assessment Program (ASAP): Using Science to Set Shelf Life Ken Waterman, PhD, Research Fellow, PFIZER, INC. |
| 9:45 |
Leverage Forced Degradation Case Studies That Facilitate Drug Discovery and Development Decision-Making Jay Xu, PhD, Senior Scientist, Structural Chemistry, ARENA PHARMACEUTICALS, INC. |
| 10:15 | 30 Minute Networking & Refreshment Break |
| 10:45 |
Development and Use of Orthogonal Methods to Analyze Drug Substance and Drug Product Pharmaceutical Degradants Fengmei Zheng, PhD, Sr. Scientist, JOHNSON & JOHNSON, PHARMACEUTICAL RESEARCH & DEVELOPMENT |
| 11:15 |
Use of Mixed-Mode Ion-Exchange Solid Phase Extraction To Characterize Pharmaceutical Drug Degradation Margaret Landis PhD, Senior Principal Scientist, PFIZER, INC. |
| 11:45 |
Orthogonal Methods and Characterization Technologies To Characterize Degradants and Impurities Panelists: Margaret Landis, PhD, Principal Scientist, Research Formulations Group, PFIZER, INC. Fengmei Zheng, PhD, Sr. Scientist, JOHNSON & JOHNSON, PHARMACEUTICAL RESEARCH & DEVELOPMENT If you are interested in participating in this panel, please contact Mike Vidoni at 212 661-3500, ext.3197, mvidoni@iirusa.com for more information |
| 12:15 | Luncheon |
| 1:15 |
Strengthen Forced Degradation Efficiencies by Implementing New High Throughput and Automated Technologies Dinos Santafianos, PhD, Principal Scientist, PFIZER, INC. |
| 1:45 |
Automated Methods Development: The New Paradigm Rosario LoBrutto, PhD, Group Head, Pharmaceutical and Analytical Development, NOVARTIS Pharmaceuticals Corporation, Co-Editor/Author HPLC for PHARMACEUTICAL SCIENTISTS (Published by Wiley) |
| 2:15 |
Biomolecule Perspective: Photostability of a Monoclonal Antibody Melissa Perkins, PhD, Director of Drug Product Development, Pharmaceutical Sciences, HUMAN GENOME SCIENCES |
| 2:45 |
Global Harmonization of Forced Degradation Studies Fenghe Qiu, PhD, Principal Scientist, Analytical Sciences, BOEHRINGER INGELHEIM |
| 3:15 | Interactive Q&A Panel with the Speakers |
| 4:00 |
Conference Concludes |
Bottom menu
Copyright 2003-2006 IIR Holdings, Ltd. All rights Reserved